IntelGenx to Report Third Quarter 2023 Financial Results on
SAINT LAURENT, Quebec, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...
Stay updated with breaking news from Genx Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAINT LAURENT, Quebec, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...
IntelGenx Technologies Corp. (OTCMKTS:IGXT – Get Free Report) saw a significant growth in short interest in October. As of October 15th, there was short interest totalling 19,300 shares, a growth of 451.4% from the September 30th total of 3,500 shares. Based on an average trading volume of 85,300 shares, the days-to-cover ratio is currently 0.2 […]
IntelGenx Technologies (OTCMKTS:IGXT – Get Free Report) and Silence Therapeutics (NASDAQ:SLN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation. Valuation & Earnings This table compares IntelGenx […]
SAINT LAURENT, Quebec, Aug. 31, 2023 -- IntelGenx Technologies Corp. announces the closing of the first tranche of a non-brokered private placement of units from atai Life Sciences AG for...
SAINT LAURENT, Quebec, Aug. 14, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the 'Company' or 'IntelGenx') toda...